Bioorganic and Medicinal Chemistry p. 1817 - 1830 (1997)
Update date:2022-07-31
Topics:
Boger, Dale L.
Haynes, Nancy-Ellen
Kitos, Paul A.
Warren, Mark S.
Ramcharan, Joseph
Marolewski, Ariane E.
Benkovic, Stephen J.
The synthesis of 10-formyl-5,8,10-trideazafolic acid (3) as a potential inhibitor of glycinamide ribonucleotide transformylase (GAR Tfase) is reported. The target compound was prepared by a convergent synthesis utilizing the alkylation of hydrazone 5 with benzylic bromide 6 to construct the core heterocycle 7. The aldehyde 3 and related agents were evaluated as inhibitors of purN GAR Tfase and avian AICAR Tfase. Compound 3 exhibited potent inhibition of GAR Tfase with a K(i) of 0.26 ± 0.05 μM. In contrast, 3 exhibited more moderate inhibition of aminoimidazole carboxamide ribonucleotide transformylase (AICAR Tfase), with K(i) of 7.6 ± 1.5 μM.
View MoreContact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Changsha Nutritopper Bio Technology Co.,Ltd.
Contact:+86-731-87803543
Address:East 1st Street, Baima Road, Ningxiang County
Contact:86-379-63338609
Address:Jiudian Village,Deting Town,Song County,Luoyang
JiYi Chemical (Beijing) Co., Ltd.
Contact:+86-10-89385733
Address:Shilou Town of Fangshan District, Beijing
Doi:10.1021/om9707228
(1997)Doi:10.1016/S0040-4039(97)10147-2
(1997)Doi:10.1248/cpb.45.1734
(1997)Doi:10.1016/j.bmcl.2017.12.056
(2018)Doi:10.1021/ja01009a027
(1968)Doi:10.1055/s-1997-1017
(1997)